Stanford
Solve GNE Raises $2.5M to Fund Gene Therapy Research at Johns Hopkins, Stanford, Biotech Firms
The nonprofit hopes its funds will help researchers quickly bring multiple gene therapy candidates for GNE myopathy to the FDA.
The firm is hopeful that its autologous chimeric engulfment receptor, or CER T cells, could get around some of the limitations seen with autologous CAR T cells.
Germline Genetic Testing Rates in Cancer Patients Low in California, Georgia, Study Finds
Only about 7 percent of cancer patients underwent testing, and rates were especially low among Black, Asian, and Hispanic patients.
Effector Therapeutics Pairs With Stanford Medicine to Study Zotatifin in High-Risk Breast Cancer
The trial will include patients with ER-positive, HER2-negative breast cancer, including a cohort with biomarker-defined high-risk disease.
Cardiac-Related Consequences of Alcohol Flushing Genetic Variant Reduced by Drug
With endothelial cells derived from induced pluripotent stem cells, researchers tracked functional changes and potential treatment targets in alcohol flushing variant carriers.
Jan 19, 2023
Jan 30, 2020